Optical Imaging for Early Lung Cancer Diagnosis
This is our 7 th year partnering with LUNGevity Foundation to support innovative early
detection of lung cancer research. We are announcing our joint effort to continue support for
the second year of research by Dr. Lida Hariri at Massachusetts General Hospital. The first
year of her ground-breaking efforts to use Optical Coherence Tomography (OCT), an emerging
technology for performing high-resolution cross-sectional imaging, to guide biopsies has shown
great promise. This methodology will facilitate reliable assessment of lung cancer. During the
second year of this project, she will initiate in vivo studies.